Recurrent Ischaemic Stroke in a Patient With Left Ventricular Thrombus Despite Apixaban: Successful Transition to Warfarin. [PDF]
CureusPatel MI, Kannan S, Jacob RM.
europepmc +1 more source
Apixaban in subclinical atrial fibrillation: stroke-driven value amid economic uncertainty. [PDF]
EuropaceYeh CH, Chen SC.
europepmc +1 more source
A Single Health System Retrospective Qualitative Analysis of Inpatient Apixaban and Rivaroxaban Calibrated Anti-Xa Level Monitoring and Clinical Implications. [PDF]
Hosp PharmMcCarville B, Osborn J.
europepmc +1 more source
Tightening Our Belts in the New Healthcare Economy [PDF]
, 2013 Pizzi, Laura, PharmD,MPH
core +1 more source
Impact of Xenobiotic Detoxification Gene Polymorphisms on Steady-State Plasma Concentrations of Apixaban and the Development of Hemorrhagic Complications in Older Patients with Non-Valvular Atrial Fibrillation. [PDF]
Genes (Basel)Kondrakhin AP +7 more
europepmc +1 more source
Direct oral anticoagulants compared to low molecular weight heparin for the treatment of venous thromboembolism among individuals with gastrointestinal cancer: an updated meta-analysis. [PDF]
Thromb JRen J, Li P.
europepmc +1 more source
Perioperative Management of Hereditary Antithrombin Deficiency in a Patient Undergoing Minimally Invasive Thoracic Surgery: A Case Report. [PDF]
Surg Case RepDomen H, Takakuwa Y, Yamada H.
europepmc +1 more source
Atrial Fibrillation in Advanced CKD: To Anticoagulate, or Not, and With What? [PDF]
Kidney360Ajmal MS, Winkelmayer WC.
europepmc +1 more source
Comparison of Apixaban with Warfarin for the Prevention of Subclinical Cerebral Infarction after Direct Current Cardioversion in Patients with Atrial Fibrillation. [PDF]
Chonnam Med JKim C +5 more
europepmc +1 more source